EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Calcium at the Helm: Mechanisms and Therapeutic Targets in the Retinal Neurovascular Unit

Siyuan Ding, Jiayi Li, Ziyi Chen iD, Wen Bai, Keran Li

Biomolecules · 22.05.2026 · 16 (6) · 763

DOI: 10.3390/biom16060763 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 22.05.2026. Verfasst von Siyuan Ding und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing 211166, China. Hauptthemen laut MEDLINE: Calcium, Retina, Retinal Diseases. Die Arbeit nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinal neurovascular unit (RNVU) dysfunction underlies major blinding and neurodegenerative conditions including glaucoma, diabetic retinopathy (DR), age-related macular degeneration (AMD), retinal ischemia–reperfusion (RIR) injury, and Alzheimer’s disease (AD)-associated retinopathy. Within the RNVU, calcium ions coordinate neurotransmission, glial activation, vascular tone, and blood–retinal barrier maintenance, and calcium dysregulation is emerging as a unifying pathogenic hub across these conditions. Although upstream triggers differ, including mechanical stress in glaucoma, hyperglycemia in DR, oxidative damage in AMD, ischemic energy failure in RIR, and amyloid-β–driven endoplasmic reticulum stress in AD, all converge on disruption of intracellular calcium homeostasis, producing shared downstream consequences including excitotoxic injury of retinal ganglion cells (RGCs), Müller cell reactive gliosis, and pericyte hypercontraction. Broad-spectrum calcium channel blockade has shown limited clinical success, underscoring the need for cell-type-specific and pathway-selective approaches. This review therefore catalogs key interventional nodes, including transient receptor potential (TRP) channel antagonists, T-type calcium channel inhibitors, calcium/calmodulin-dependent protein kinase II (CaMKII) suppressors, and mitochondrial permeability transition pore (mPTP) inhibitors, and discusses how precision targeting of these pathways may restore RNVU homeostasis and open a therapeutic window into central nervous system (CNS) degenerative disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalciumRetinaRetinal DiseasesHumansAnimalsDiabetic RetinopathyGlaucomaBlood-Retinal BarrierCalcium Channel BlockersRetinal Ganglion Cells

Stichwörter der Autor:innen

TRP channelsage-related macular degenerationcalcium signalingdiabetic retinopathyglaucomaneurovascular unitretina

Substanzen

CalciumCalcium Channel Blockers

Autor:innen und Institutionen

  • The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing 211166, China.
  • Department of Ophthalmology, The Affiliated Eye Hospital of Nanjing Medical University, Nanjing 210029, China.

ORCID-Profile: Ziyi Chen

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Ding, S., Li, J., Chen, Z., Bai, W., & Li, K. (2026). Calcium at the Helm: Mechanisms and Therapeutic Targets in the Retinal Neurovascular Unit. Biomolecules, 16(6), 763. https://doi.org/10.3390/biom16060763

Vancouver

Ding S, Li J, Chen Z, Bai W, Li K. Calcium at the Helm: Mechanisms and Therapeutic Targets in the Retinal Neurovascular Unit. Biomolecules. 2026;16(6):763. doi:10.3390/biom16060763

BibTeX
@article{Ding2026,
  author = {Ding, Siyuan and Li, Jiayi and Chen, Ziyi and Bai, Wen and Li, Keran},
  title = {Calcium at the Helm: Mechanisms and Therapeutic Targets in the Retinal Neurovascular Unit},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {763},
  doi = {10.3390/biom16060763}
}
Kostenlos starten →